A pharmacological method of measuring mouth caecal transit time in man.
作者信息
Kennedy M, Chinwah P, Wade D N
出版信息
Br J Clin Pharmacol. 1979 Oct;8(4):372-3. doi: 10.1111/j.1365-2125.1979.tb04723.x.
Abstract
摘要
相似文献
1
A pharmacological method of measuring mouth caecal transit time in man.一种测量人体口腔至盲肠转运时间的药理学方法。
Br J Clin Pharmacol. 1979 Oct;8(4):372-3. doi: 10.1111/j.1365-2125.1979.tb04723.x.
2
Oro-caecal transit time in man assessed by the sulfasalazine/sulfapyridine test. Correlation between plasma-saliva appearance of sulfapyridine.通过柳氮磺胺吡啶/磺胺吡啶试验评估人体口腔至盲肠转运时间。磺胺吡啶血浆-唾液出现时间的相关性。
Fundam Clin Pharmacol. 1992;6(8-9):383-5. doi: 10.1111/j.1472-8206.1992.tb00134.x.
3
Effect of exercise on mouth-to-cecum transit in trained athletes: a case against the role of runners' abdominal bouncing.运动对训练有素的运动员口腔至盲肠转运时间的影响：对跑步者腹部跳动作用的质疑
J Sports Med Phys Fitness. 1996 Dec;36(4):271-4.
4
[Cecal motricity and ceco-iliac transit in the horse].[马的盲肠动力和盲肠-回肠运输]
C R Seances Soc Biol Fil. 1975;169(6):1617-21.
5
Assessment of the reproducibility of the lactulose H2 breath test as a measure of mouth to caecum transit time.评估乳果糖氢呼气试验作为测量口腔至盲肠转运时间的可重复性。
Gut. 1983 Oct;24(10):893-6. doi: 10.1136/gut.24.10.893.
6
An HPLC assay for sulphapyridine in plasma and its use to assess small bowel transit time after the administration of sulphasalazine.血浆中磺胺吡啶的高效液相色谱测定法及其在评估柳氮磺胺吡啶给药后小肠转运时间中的应用。
Int J Clin Pharmacol Ther Toxicol. 1987 Jul;25(7):406-9.
7
[Modification of orocecal transit time of salazosulfapyridine by atropine and metoclopramide in healthy probands].[阿托品和胃复安对健康受试者柳氮磺胺吡啶口腔至盲肠转运时间的影响]
Dtsch Z Verdau Stoffwechselkr. 1986;46(6):327-32.
8
Effect of a new oral somatostatin analog (SDZ CO 611) on gastric emptying, mouth to cecum transit time, and pancreatic and gut hormone release in normal male subjects.一种新型口服生长抑素类似物（SDZ CO 611）对正常男性受试者胃排空、口至盲肠转运时间以及胰腺和肠道激素释放的影响。
J Clin Endocrinol Metab. 1994 Feb;78(2):329-36. doi: 10.1210/jcem.78.2.7906279.
9
10
Redox potential in caecal contents of the rat and azo reduction of salicyl-azo-sulphapyridine.大鼠盲肠内容物中的氧化还原电位及水杨偶氮磺胺吡啶的偶氮还原作用
Xenobiotica. 1973 Apr;3(4):233-46. doi: 10.3109/00498257309151519.
引用本文的文献
1
An Advanced Bioreactor Simulating Dynamic Physiological Conditions in the Human Ascending Colon: MimiCol.一种模拟人体升结肠动态生理条件的先进生物反应器：MimiCol。
Pharmaceutics. 2022 May 13;14(5):1049. doi: 10.3390/pharmaceutics14051049.
2
Application of In Vivo Imaging Techniques and Diagnostic Tools in Oral Drug Delivery Research.体内成像技术与诊断工具在口腔给药研究中的应用
Pharmaceutics. 2022 Apr 6;14(4):801. doi: 10.3390/pharmaceutics14040801.
3
Formulation and In Vitro Evaluation of Pellets Containing Sulfasalazine and Caffeine to Verify Ileo-Colonic Drug Delivery.含柳氮磺胺吡啶和咖啡因的微丸制剂的制备及体外评价以验证回肠-结肠给药
Pharmaceutics. 2021 Nov 23;13(12):1985. doi: 10.3390/pharmaceutics13121985.
4
The effect of bariatric surgery on intestinal absorption and transit time.减重手术对肠道吸收和传输时间的影响。
Obes Surg. 2014 May;24(5):796-805. doi: 10.1007/s11695-013-1166-x.
5
Clinical pharmacokinetics of metformin.二甲双胍的临床药代动力学。
Clin Pharmacokinet. 2011 Feb;50(2):81-98. doi: 10.2165/11534750-000000000-00000.
6
Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.地高辛口服生物利用度增加及非肾小球性肾清除率降低对地高辛-克拉霉素相互作用的影响。
Br J Clin Pharmacol. 2003 Jul;56(1):32-8. doi: 10.1046/j.1365-2125.2003.01824.x.
7
Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea.患有和未患有腹泻的艾滋病患者的小肠转运、吸收及通透性
Gut. 1999 Jul;45(1):70-6. doi: 10.1136/gut.45.1.70.
8
Application of a simplified method to determine bioavailability of an oral dose of phenytoin.一种用于确定口服苯妥英剂量生物利用度的简化方法的应用。
J Pharmacokinet Biopharm. 1993 Apr;21(2):195-208. doi: 10.1007/BF01059770.
9
Oxprenolol absorption in man after single bolus dosing into two segments of the colon compared with that after oral dosing.与口服给药后相比，单次大剂量给药至结肠的两个节段后人体内氧烯洛尔的吸收情况。
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):137S-142S. doi: 10.1111/j.1365-2125.1985.tb02754.x.
10
The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation.人体药物的胃肠道吸收：当前概念与研究方法综述
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):77S-83S. doi: 10.1111/j.1365-2125.1985.tb02746.x.
本文引用的文献
1
Production and excretion of hydrogen gas in man.人体中氢气的产生与排泄
N Engl J Med. 1969 Jul 17;281(3):122-7. doi: 10.1056/NEJM196907172810303.
2
Absorption, metabolism, and excretion of salicylazosulfapyridine in man.柳氮磺胺吡啶在人体中的吸收、代谢及排泄
Clin Pharmacol Ther. 1972 Jul-Aug;13(4):539-51. doi: 10.1002/cpt1972134539.
3
Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis. Effects of colectomy and of phenobarbital.柳氮磺胺吡啶在健康受试者及溃疡性结肠炎患者中的代谢。结肠切除术及苯巴比妥的影响。
Clin Pharmacol Ther. 1973 Sep-Oct;14(5):802-9. doi: 10.1002/cpt1973145802.
4
Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements.利用肺部氢气（H2）测量法对人体小肠转运时间的研究。
J Lab Clin Med. 1975 Apr;85(4):546-55.
5
Delayed small-intestinal transit in tropical malabsorption.热带吸收不良时小肠转运延迟。
Br Med J. 1978 Jul 22;2(6132):238-40. doi: 10.1136/bmj.2.6132.238.
Zotero 插件